Results 71 to 80 of about 646,835 (301)

Eagle's Syndrome

open access: yesInternal Medicine, 2022
Miyagawa, Shun   +3 more
openaire   +5 more sources

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Completing Markets in a One-Good, Pure Exchange Economy Without State-Contingent Securities [PDF]

open access: yes
Pareto-efficient consumption in a pure-exchange, one good economy varies over states of nature with respect to only two factors: real aggregate supply and individual utility shocks.
David Eagle
core  

Volume 25, Number 1 - February 1947 [PDF]

open access: yes, 1947
Volume 25, Number 1 – February 1947. 58 pages including covers and advertisements. Editorial Doherty, R.E. The Beast O\u27Brien, John J. On Coffee Eagle, George L. A Stranger in Strasbourg Shanley, Joseph V. Reflections Doherty, R.E.

core   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

open access: yesMolecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute   +4 more
wiley   +1 more source

Two\u27s Company but Three\u27s a Crowd: A Study on the Crowd in the Book of Acts [PDF]

open access: yes, 2015
The book of Acts is an entity of its own. While it is a part of the canonical Bible as one of the sixty-six books, it is unique in that it presents the continuation of God’s plan from Jesus Christ to the growth of the early Christian church.
Eagle, Dylan
core   +1 more source

Two-Stage Eagle Strategy with Differential Evolution [PDF]

open access: yes, 2012
Efficiency of an optimization process is largely determined by the search algorithm and its fundamental characteristics. In a given optimization, a single type of algorithm is used in most applications.
Deb, Suash, Yang, Xin-She
core   +1 more source

Establishment of a coculture system for Porphyromonas gingivalis and head and neck squamous cell carcinoma using spheroid culture and LATS inhibition

open access: yesFEBS Open Bio, EarlyView.
We established a spheroid coculture system enabling viable Porphyromonas gingivalis–HNSCC interactions under normoxic conditions. Inhibition of LATS1/2 maintains tumor cells in an undifferentiated state, which may promote spheroid growth and create a more permissive environment for bacterial persistence.
Yurika Nakajima   +4 more
wiley   +1 more source

EAGLE—A Scalable Query Processing Engine for Linked Sensor Data [PDF]

open access: yes, 2019
Recently, many approaches have been proposed to manage sensor data using semantic web technologies for effective heterogeneous data integration. However, our empirical observations revealed that these solutions primarily focused on semantic relationships
G. Breslin, John   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy